G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner
Lei Hu(Anhui Medical University), Zhiyuan Fan(Shanghai First Maternity and Infant Hospital), Zhiqiang Zhu(University of Science and Technology of China), Hexiao Wang(Memorial Sloan Kettering Cancer Center), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Min Yan(Zhengzhou University), Jianfang Li(Shanghai Jiao Tong University), Liping Su(Guangdong Provincial People's Hospital), Qiang Huang(Hubei University of Medicine), Zhenqiang Wang(Qilu University of Technology), Huo Wu(First Affiliated Hospital of Anhui Medical University), Mingde Zang(Fudan University Shanghai Cancer Center), Zhang Bao-gui(Affiliated Hospital of Jining Medical University)
Cited by 79
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
|World Journal of Gastroenterology|2018|212